DUBLIN, Oct. 1, 2026 /PRNewswire/ -- Ensera, a global CDMO specializing in commercialization support for injectable drug programs, has launched the Ensera Alliance Network, bringing together leading device platform and fill-finish specialists to address the complexity of commercializing drug-device combination products.
Read more at prnewswire.comEnsera launches alliance network with SHL Medical, Stevanato Group, Ypsomed, Argonaut and American Injectables
Barchart·10/01/2026 03:00:00
语音播报
This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.